Pancreatic Cancer Research

ResearcherYamaguchi UniversityActive in the last 2 years

Yutaka Suehiro

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-8822-0053; OpenAlex author ID A5102995518. Sources: OpenAlex.

Their work

Papers
5 (first author 3, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
19
Papers, trials and grants by year

2013: 1 paper · 2014: 1 paper · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: 1 paper · 2022: 1 paper · 2023: none · 2024: none · 2025: none · 2026: 1 paper

Papers 5

  1. A Novel Index Consisting of Age, CA19-9, and Methylated Somatostatin Is Useful for Diagnosing Early Pancreatic Cancer. First author DOI 10.1002/cam4.72202↗
  2. CA19-9 in Combination with Methylated HOXA1 and SST Is Useful to Diagnose Stage I Pancreatic Cancer. Co-author DOI 10.1159/000527342↗
  3. Combination of CA19-9 and Blood Free-Circulating Methylated RUNX3 May Be Useful to Diagnose Stage I Pancreatic Cancer. First author DOI 10.1159/000511940↗
  4. Adoptive immunotherapy with MUC1-mRNA transfected dendritic cells and cytotoxic lymphocytes plus gemcitabine for unresectable pancreatic cancer. Co-author DOI 10.1186/1479-5876-12-175↗
  5. TWIST1 hypermethylation is observed in pancreatic cancer. First author DOI 10.3892/br.2012.25↗

Closest collaborators

The 19 strongest of 19 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Takahiro Yamasaki · 4 shared papers, 2014–2026 · strength 0.52
  2. Taro Takami · 3 shared papers, 2021–2026 · strength 0.48
  3. Shigeyuki Suenaga · 3 shared papers, 2021–2026 · strength 0.48
  4. Kaori Hamamoto · 2 shared papers, 2022–2026 · strength 0.37
  5. Isao Sakaida · 3 shared papers, 2013–2022 · strength 0.28
  6. Hiroto Matsui Matsui · 3 shared papers, 2014–2022 · strength 0.26
  7. Shoko Tabara · 1 shared paper, 2026 · strength 0.26
  8. Shuhei Shinoda · 1 shared paper, 2026 · strength 0.26
  9. Yuko Fujimoto · 2 shared papers, 2021–2022 · strength 0.23
  10. Shogo Amano · 1 shared paper, 2022 · strength 0.12
  11. Hiroaki Nagano · 1 shared paper, 2022 · strength 0.12
  12. Keiko Shinjo · 1 shared paper, 2022 · strength 0.12
  13. Yutaka Kondo · 1 shared paper, 2022 · strength 0.12
  14. Hiroaki Nagano · 1 shared paper, 2021 · strength 0.11
  15. Manabu Sen-yo · 1 shared paper, 2013 · strength 0.05
  16. Masaaki Oka · 1 shared paper, 2014 · strength 0.04
  17. Tomio Ueno · 1 shared paper, 2014 · strength 0.04
  18. Yoshitaro Shindo · 1 shared paper, 2014 · strength 0.04
  19. Nobuaki Suzuki · 1 shared paper, 2014 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.